Ananda Ghosh
Stock Analyst at HC Wainwright & Co.
(3.89)
# 717
Out of 5,056 analysts
14
Total ratings
53.85%
Success rate
13.58%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ananda Ghosh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PEPG PepGen | Maintains: Buy | $18 → $20 | $5.74 | +248.43% | 3 | Nov 13, 2025 | |
| DYN Dyne Therapeutics | Maintains: Buy | $38 → $46 | $20.96 | +119.47% | 1 | Nov 6, 2025 | |
| RNA Avidity Biosciences | Downgrades: Neutral | $87 → $72 | $70.85 | +1.62% | 2 | Oct 27, 2025 | |
| IVA Inventiva | Maintains: Buy | $20 → $24 | $4.18 | +474.16% | 2 | Oct 9, 2025 | |
| SKYE Skye Bioscience | Initiates: Buy | $20 | $1.33 | +1,403.76% | 1 | Sep 30, 2025 | |
| MAZE Maze Therapeutics | Reiterates: Buy | $50 | $33.23 | +50.47% | 3 | Sep 18, 2025 | |
| ANNX Annexon | Reiterates: Buy | $14 | $3.20 | +337.50% | 1 | Aug 15, 2025 | |
| GPCR Structure Therapeutics | Maintains: Buy | $75 → $60 | $34.50 | +73.91% | 1 | Aug 7, 2025 |
PepGen
Nov 13, 2025
Maintains: Buy
Price Target: $18 → $20
Current: $5.74
Upside: +248.43%
Dyne Therapeutics
Nov 6, 2025
Maintains: Buy
Price Target: $38 → $46
Current: $20.96
Upside: +119.47%
Avidity Biosciences
Oct 27, 2025
Downgrades: Neutral
Price Target: $87 → $72
Current: $70.85
Upside: +1.62%
Inventiva
Oct 9, 2025
Maintains: Buy
Price Target: $20 → $24
Current: $4.18
Upside: +474.16%
Skye Bioscience
Sep 30, 2025
Initiates: Buy
Price Target: $20
Current: $1.33
Upside: +1,403.76%
Maze Therapeutics
Sep 18, 2025
Reiterates: Buy
Price Target: $50
Current: $33.23
Upside: +50.47%
Annexon
Aug 15, 2025
Reiterates: Buy
Price Target: $14
Current: $3.20
Upside: +337.50%
Structure Therapeutics
Aug 7, 2025
Maintains: Buy
Price Target: $75 → $60
Current: $34.50
Upside: +73.91%